Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1968;37:424-428

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HELFANT, R. H.
Right arrow Articles by DAMATO, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HELFANT, R. H.
Right arrow Articles by DAMATO, A. N.

(Circulation. 1968;37:424.)
© 1968 American Heart Association, Inc.


Diphenylhydantoin Prevention of Arrhythmias in the Digitalis-Sensitized Dog after Direct-Current Cardioversion

RICHARD H. HELFANT M.D.1; BENJAMIN J. SCHERLAG PH.D.1; ANTHONY N. DAMATO M.D.1

1 From the Cardiopulmonary Laboratory, U. S. Public Health Service Hospital, Staten Island, New York.

The ability of diphenylhydantoin to prevent arrhythmias induced by synchronized direct current shocks after digitalis sensitization was evaluated. In the control state, an average of 155 watt-seconds was required to produce ventricular tachycardia. Immediately after recovery from digitalis toxicity, an average of 23 watt-seconds produced ventricular tachycardia. The administration of diphenylhydantoin at this time immediately increased the threshold required for ventricular tachycardia to an average of 363 watt-seconds. In eight studies, diphenylhydantoin was given during cardioversion-induced ventricular tachycardia and converted all cases to regular sinus rhythm. These findings indicate that diphenylhydantoin may be of prophylactic value prior to direct current cardioversion in a digitalized patient. Conversely, diphenylhydantoin would also be useful in the management of ectopic beats that may occur in digitalized patients after cardioversion.


Key Words: Ectopic beats • Electrical energy threshold • Ventricular automaticity